Table 1 Demographic and clinical characteristics of patients according to HIV status
From: Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
People without known HIV (N = 300) | People with HIV (N = 22) | P-value | |
|---|---|---|---|
Patient age (years) | 38 (31, 50) | 48 (34, 57) | 0.02 1 |
Length of stay (days) | 6 (3, 15) | 10 (5, 31) | 0.02 1 |
Sex (Male) | 176 (59%) | 15 (68%) | 0.38 2 |
Race | |||
White | 203 (68%) | 10 (45%) | 0.06 3 |
Black | 89 (30%) | 12 (55%) | |
Other | 8 (3%) | 0 | |
Insurance status | |||
Medicaid | 141 (47%) | 17 (77%) | 0.20 3 |
Uninsured | 94 (31%) | 4 (18%) | |
Medicare | 23 (8%) | 0 (0%) | |
Not documented | 15 (5%) | 1 (5%) | |
Other | 15 (5%) | 0 (0%) | |
Commercial | 12 (4%) | 0 (0%) | |
Housing status | |||
Stable | 146 (49%) | 10 (46%) | 0.51 2 |
Unstable | 105 (35%) | 10 (46%) | |
Unknown | 49 (16%) | 2 (9%) | |
Discharge status | |||
Routine | 231 (77%) | 18 (82%) | 0.999 3 |
PDD | 60 (20%) | 4 (18%) | |
Death | 5 (2%) | 0 | |
Other | 4 (1%) | 0 | |
Infection causing hospitalization | |||
SSTI | 197 (66%) | 12 (55%) | 0.29 2 |
Bacteremia | 101 (34%) | 9 (41%) | 0.49 2 |
Endocarditis | 49 (16%) | 2 (9%) | 0.37 2 |
Osteomyelitis | 44 (15%) | 4 (18%) | 0.66 2 |
Other | 33 (11%) | 3 (14%) | 0.70 2 |
Epidural abscess | 17 (6%) | 2 (9%) | 0.51 2 |
Septic arthritis | 12 (4%) | 2 (9%) | 0.26 3 |
Inpatient consultation performed | |||
Addiction medicine | 164 (55%) | 18 (82%) | 0.01 2 |
Infectious diseases | 132 (44%) | 11 (50%) | 0.58 2 |
Return to acute care within one year | |||
Emergency department visit | 148 (50%) | 15 (68%) | 0.10 2 |
N/A (Death during SA) | 5 (2%) | 0 (0%) | |
Readmission | 146 (49%) | 13 (59%) | 0.39 2 |
N/A (Death during SA) | 5 (2%) | 0 (0%) | |
MOUD prescription | |||
Initiated during stay | 60 (28%) | 5 (31%) | 0.79 2 |
On MOUD prior to admission | 87 (29%) | 6 (27%) | |
Provided on discharge | 123 (42%) | 6 (27%) | 0.18 2 |
N/A (Death during SA) | 5 (2%) | 0 (0%) | |
PrEP continuum | |||
HIV screening test performed | 168 (56%) | N/A | |
Present during admission | 0 (0%) | N/A | |
Eligible | 300 (100%) | 0 (0%) | |
Documented discussion | 2 (1%) | N/A | |
Prescribed on discharge | 1 (< 1%) | N/A | |
Linked to PrEP follow-up care | 0 (0%) | N/A | |
HIV-specific outcomes | |||
Viral load collected during admission | N/A | 13 (59%) | |
Viremia present | N/A | 13 (59%) | |
Median HIV viral load | N/A | 6226 copies/mL | |
Median CD4 count | N/A | 206 cells/mm3 | |
Antiretroviral therapy POA | N/A | 7 (37%) | |
Antiretroviral therapy on discharge | N/A | 11 (50%) | |
Successfully linked to care | N/A | 10 (45%) | |
Viral load negative within 1 year | N/A | 4 (18%) | |